Novartis International AG / J.A.M.I.E. Group / Novartis Group / Novartis AG / Serogroup / Twitter / /
Continent
North America / Europe / /
Country
Switzerland / United States / Canada / Australia / /
Currency
USD / / /
Event
FDA Phase / /
Facility
Princeton University / University Campuses / University of California / /
IndustryTerm
over-the-counter and animal health products / generic pharmaceuticals / healthcare solutions / prevention of meningitis / /
MedicalCondition
bacterial meningitis / meningococcal disease / meningitis B / invasive meningococcal disease / only meningitis B / disease / vaccine-preventable disease / Symptoms - Meningococcal Meningitis / meningitis / /
MedicalTreatment
active immunization / vaccination / /
NaturalFeature
Saguenay / /
Organization
University of California / Santa Barbara / The J / Princeton University / US Securities and Exchange Commission / Advisory Committee on Immunization Practices / US Food and Drug Administration / European Commission / FDA / European Union / US Centers for Disease Control and Prevention / /
Person
Richard Pulik Susan Donofrio / Andrin Oswald / Jamie Schanbaum / Samir Shah Pierre-Michel Bringer / Thomas Hungerbuehler Isabella Zinck / Liz Power / / /
Position
Division Head / /
Product
Bexsero / Bexsero® / B vaccine / US / Europe / FDA / /
Novartis International AG Novartis Global Communications CH-4002 Basel Switzerland http://www.novartis.com